S

Syntax Bio

HealthUnited States

Syntax Bio is a biotechnology company focused on developing innovative therapies for genetic diseases. The company aims to address unmet medical needs through its proprietary technology platform. This funding round will help expand its leadership team and board members, enhancing its strategic direction.

$14.4M · Series AVisit website ↗